Published in TB and Outbreaks Week, December 11th, 2001
Nacer Lounis and colleagues at the Faculte de Medecine Pitie-Salpetriere in Paris, the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, and the nonprofit Global Alliance for TB Drug Development in New York City evaluated the efficacy of moxifloxacin in mice.
The broad-spectrum antibiotic appeared to enhance the effectiveness of isoniazid, they reported.
The researchers examined mice infected with 1.6 x 107/cfu of Mycobacterium...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.